Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Number 6—June 2022
Research

Retrospective Genomic Characterization of a 2017 Dengue Virus Outbreak, Burkina Faso

Andrew G. Letizia1, Catherine B. Pratt1Comments to Author , Michael R. Wiley, Anne T. Fox, Mba Mosore, Bright Agbodzi, Clara Yeboah, Selassie Kumordjie, Nicholas Di Paola, Kone Cisse Assana, David Coulidiaty, Casimir Ouedraogo, Joseph H. Kofi Bonney, William Ampofo, Zékiba Tarnagda, and Lassana SangaréComments to Author 
Author affiliations: Naval Medical Research Unit TWO, Singapore (A.G. Letizia); University of Nebraska Medical Center, Omaha, Nebraska, USA (C.B. Pratt, M.R. Wiley); Naval Medical Research Unit THREE, Ghana Detachment, Accra, Ghana (A.T. Fox); Noguchi Memorial Institute for Medical Research, Accra (M. Mosore, B. Agbodzi, C. Yeboah, S. Kumordjie, J.H.K. Bonney, W. Ampofo); US Army Medical Research Institute of Infectious Disease, Frederick, Maryland, USA (N. Di Paola); Institut de Recherche en Sciences de la Santé, Bobo-Dioulasso, Burkina Faso (K.C. Assana, Z. Tarnagda); Centre Hospitalier Universitaire Yalgado Ouédraogo, Ouagadougou, Burkina Faso (D. Coulidiaty, C. Ouedraogo, L. Sangaré)

Main Article

Figure 6

Dengue virus prM and E protein sequence alignments of Dengvaxia and TetraVax-DV-TV003 vaccine strains (boldface) and 2017 Burkina Faso dengue virus outbreak genomes for serotypes 1, 2, and 3. Only amino acid positions with disagreements are shown; single-point disagreements are highlighted. For clarity, prM protein sequences are shaded in red. Numerals represent the prM and E protein amino acid position. CYD, Dengvaxia vaccine; DENV-1, dengue virus serotype 1; DENV-2, dengue virus serotype 2; DENV-3, dengue virus serotype 3; E, envelope; prM, premembrane; TV003, TetraVax-DV-TV003 vaccine.

Figure 6. Dengue virus prM and E protein sequence alignments of Dengvaxia and TetraVax-DV-TV003 vaccine strains (boldface) and 2017 Burkina Faso dengue virus outbreak genomes for serotypes 1, 2, and 3. Only amino acid positions with disagreements are shown; single-point disagreements are highlighted. For clarity, prM protein sequences are shaded in red. Numerals represent the prM and E protein amino acid position. CYD, Dengvaxia vaccine; DENV-1, dengue virus serotype 1; DENV-2, dengue virus serotype 2; DENV-3, dengue virus serotype 3; E, envelope; prM, premembrane; TV003, TetraVax-DV-TV003 vaccine.

Main Article

1These first authors contributed equally to this article.

Page created: March 18, 2022
Page updated: May 22, 2022
Page reviewed: May 22, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external